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THE PHARMACOLOGY OP PYRETHRUM FLOWERS
P a rt I .  The H isto ry  and Uses of Pyrethrura Flowers,
The e a r ly  h is to ry  of pyrethrura flow ers or in sec t powder is  very much 
confused h u t i t  i s  known th a t  the people of e a s te rn  Europe were aware of 
the  value o f pyrethrum as an in se c tic id e  more than a  cen tury  ago and th a t 
in se c t flow ers were used s t i l l  e a r l i e r  in  Dalmatia under the name of 
“Polvere de P u lis i"  (1 ) .
The use o f in se c t powder was exposed to w estern Europe by Sum ttoff, 
an Armenian m erchant, who w hile tra v e lin g  through the Caucasian t e r r i to r y  
became cognizant of the f a c t  th a t in sec t powder was made from the flow ers 
o f Pyrethrum rosem and Pyrethrum cameum (2 ) , Sum t o f f ’ s son became the 
f i r s t  m anufacturer o f the powder on a commercial b a s is . Another re p o rt 
s ta te s  th a t  Teherkess p riso n e rs  re la te d  the formula of in se c t powder to 
R ussian m il i ta ry  a u th o r it ie s .
About 1840, Pyrethrura c inera riaefo llu m  was produced in  Dalmatia and 
soon began to  rep lace th e  P e rs ian  species in  Europe. The o r ig in  of the 
r is e  o f th is  spec ies  as an in se c tic id e  is  very in te re s tin g . A German 
woman l iv in g  in  Ragusa, D alm atia, picked a  bunch o f flow ers fo r  decorative 
purposes, l a t e r  throwing them in  a corner a f t e r  they had become w ithered . 
A fte r  a sh o rt time she n o ticed  dead in sec ts  near the flow ers and b e lie v ­
ing th a t  the in sec ts  d ied because of some ac tio n  of the flow ers, she un­
dertook the manufacture of in se c t powder, which was continued a f t e r  her
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death  by a  pharm acist o f Ragusa (3 ).
Pyrethrum powder was in troduced in to  the U nited S ta te s  about 1860 (4)t 
U n til 1914 p ra c t ic a l ly  a l l  pyrethrum used in  th i s  country was imported 
from Dalmatia bu t the World War c losed  th is  market and Japan was quick to 
se is e  th is  opportun ity  to supply in se c t powder. Japan was ab le  to  do 
th i s  owing to the f a c t  th a t pyrethrum flow ers had been in troduced  in to  
th a t  country from England in  1881, from Dalmatia in  1864 and 1885, and 
from A u stria  in  1866.
In  recen t y ea rs , enormous q u a n ti t ie s  of in se c t powder have been im­
p orted  in to  the U nited S ta te s  from many c o u n tr ie s , but the q u a n ti t ie s  
from Japan a re  f a r  in  excess of the combined q u a n titie s  from a l l  o ther 
co u n trie s .
The imported powder must be obtained  from Chrysanthemum (Pyrethrum) 
c in era riae fo liu m  (T rev .} B occ., Chrysanthemum (Pyrethrum) roseum Web. 
and Mohr., o r  Chrysanthemum M arsh a llii Aschers (synonym, Pyrethrum 
cameum M.B.) ,  a l l  o f these being recognized as sources o f in sec t flow ers 
by the In se c tic id e  and Fungicide Board of the United S ta te s  Department of 
A g ricu ltu re  (5 ). Of the th re e , Pyrethrum c in erariaefo liu m  i s  the most im­
p o rta n t commercially, s ince  very small q u a n titie s  of Pyrethrum roseum 
and Pyrethrum cameum are  imported in to  the United S ta te s .
Table I  supplied  by the United S ta te s  Department of Commerce shows 
the  e x te n t to which Japan monopolizes th e  pyrethrum im portations in to  th is  
country.
TABLE I , Imports in to  U nited S ta te s  of Pyrethrum Flow ers, Crude
1923 1924 1925
Pounds Value Pounds Value Pounds Value
Japan 2,514,251 
Yugoslavia 67,296 
I t a l y  389,056 
A u s tr ia  3,260
United Kingdom----



































Total 2,973,863 #1,397,910 3,945,101 #1,603,764 6,435,405 #1,236,892
1926 1927 1928
Pounds Value Pounds Value Pounds Value
Japan 8,061,209 
Yugoslavia 221,919 
I t a ly  1,512,711 
A u s tria
Belgium ----
France —  
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Total 9,859,850 #1,219,365 8,993,109 #1,220,107 13,689,009 #3,692,126
1929 1930 1931
Founds Value Pounds Value Pounds Value
Japan 8,814,931 
Yugoslavia 88,646 





































T otal 9,013,077 #2,060,884 8,536,426 #1,333,016 4,521,143 # 522,103
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1932 1953 1954
Pounds Value Pounds Value Pounds Value
Japan 11,061,949 $1,206,692 9,066,040 $1,S73,45Q 10,093,612 $1,985,603
Yugoslavia 612,965 59,910 838,256 94,372 298,684 47,596
I t a ly  412,658 41,865 446,197 52,072 113,533 17,152
Tfialted Kingd o m   - — — -  —-  42,369 6,340
R ussia  14,164 625 3,855 3,855 38,093 1,714
B ra s il  -  —-  '     4,480 1,086
T otal 12,110,736 $1,309,092 10,434,559 $1,523,749 10,590,771 $2,059,492 
In  a d d itio n  to the fo regoing  imports o f  crude pyrethrum, sp e c ia l 
p ro v is io n  has been mads in  the import s t a t i s t i c a l  records f o r  "Pyrethrum, 
advanced in  value o r co n d itio n ."*  E n tr ie s  under th is  d e sc rip tio n  have 
been as fo llo w s:
Year Pounds Value Year Pounds Value
1923 185,603 $81,270 1929 23,240 $ 6,524
1924 44,777 19,829 1930 31,200 6,817
1926 31,908 9,895 1931 15,770 3,056
1926 13,638 3,015 1932 25,010 3,066
1927 30,786 6,237 1933 60,747 12,147
1928 58,721 14,364 1934 150,370** 36,502
At one tim e, pyrethrum was grown commercially in  c e n tra l  C a lifo rn ia , 
but the hand lab o r req u ired  f o r  p ick ing  the flow ers made co s ts  of crop 
production  too h igh to compete w ith  imported sup p lies .
In  ad d itio n  to in s e c tic id a l  p ro p e r t ie s ,  i t  is  claimed th a t pyrethrum 
flow ers a lso  have some v ir tu e  as an anthelm intic* The e a r l i e s t  rep o rts
* "Pyrethrum advanced in  c la s s ,"  is  probably pyrethrum ground to a  very 
f in e  powder,
** Japan 149,250 pounds ($36,148) and I ta ly  1,120 pounds ($354).
of suoh use were made by Sohipulinsky (6) in  1854, by F ro n ta l!  (7) in  
1858, and by Noodt (8) in  1858. The f i r s t  suggestion in  th is  country  of 
verm ioidal p ro p e rtie s  was made by a physician  in  1898 (9) who through an 
acc iden t to a ch ild  discovered th is  p roperty  of in sec t flow ers . In  more 
recen t y ea rs , C hevalier (10, 11), Gaudin and Carron (1 2 ), Anglade, 
Gaudin, and Arcony (13), and F e rro t (14) have rep o rted  such w idespread 
successes w ith  pyrethrum as an an th e lm in tic  th a t  sev era l p rep ara tio n s  
a re  now marketed in  France and are  ex ten s iv e ly  used fo r  t h i s  type of 
m edication. Gnadinger (15) in  the U nited S ta te s  re p o rts  th a t h is  suc­
cesses in  th i s  d ire c tio n  have not been n early  as sp e c ta c u la r  as those 
of the  o th e r in v e s tig a to rs .
In se c t flow ers have a lso  been described  as u se fu l in  the  treatm ent 
of sc a b ie s , by Lem&ire and Graudin (16) in  France and by Sw eitzer and 
Tedder (17) in  th e  U nited S ta te s . An ointment con tain ing  0.75 p e r cent 
p y re th rin s , rep resen tin g  83 grams pyrethrum per 100 grams of product 
has re ce n tly  been made av a ilab le  to physicians in  the U nited S ta te s  f o r  
use in  the treatm ent of th is  d isease .
P a r t  I I .  The A ctive P r in c ip le s  o f Pyrethrum Flowers.
The middle o f the n in e teen th  cen tu ry  marked, the beginning o f many 
attem pts to  i s o la te  the  a c tiv e  p r in c ip le  o r p r in c ip le s  of in se c t flow ers . 
Uany conclusions appeared, such as the presence of v o la t i le  o i l s ,  san­
to n in , r e s in s ,  a c id s , o le o re s in s , and e s te r s  (18), a l l  o f which a t  some 
time were considered responsib le  f o r  the in s e c t ic id a l  powers o f in se c t
flow ers. However, f o r  various reasons, none of these conclusions have
w ithstood  the t e s t  of time.
In  1924, S taudinger and Ruzicka (19) published  a  s e r ie s  of papers 
in  which were described  the  i s o la t io n ,  chemical in v e s tig a tio n , and 
attem pts to syn thesize  two a c tiv e  c o n s titu e n ts  designated  as p y re th rin  1 
and p y re th r in  I I ,  These two substances were repo rted  as rep re sen tin g
the t o t a l  a c t iv i ty  o f in se c t flow ers.
I t  i s  un fo rtunate  th a t  the name p y re th rin  was used to designate  the 
a c tiv e  co n s titu en ts  of in se c t flow ers because th is  name had a lread y  
been used to  id e n tify  the a c tiv e  p r in c ip le  o f Anaeyclus pyrethrum (20) 
a lso  known as p e l l i to r y ,  Anaeyclus pyrethrum was o f f i c i a l  in  U .S.P. IX 
and i s  used as an i r r i t a n t ,  apparently having abso lu te ly  no in s e c t ic id a l  
p ro p e rtie s .
During the course of the work to  be described , i t  was noted th a t  
pyrethrum powder or so lu tio n s  exposed to  a i r  very quickly  d e te r io ra te d .
I t  was a lso  observed th a t roaches and f l i e s  apparen tly  p ro te c ted  from
co n tac t w ith  the powder hut no t from vapors p o ssib ly  em itted , re a d ily  
showed symptoms of pyrethrum ac tio n . This led  to  the b e l ie f  th a t some 
samples o f pyrethrum may con ta in  some p ro p o rtio n  of v o la t i le  a c t iv i ty .
In  fo llow ing th is  suggestion , 600 grams o f in se c t  flow ers were 
steam d i s t i l l e d  and 4 l i t e r s  of d i s t i l l a t e  c o lle c te d  in  250 c .o . f r a c ­
t io n s . Some of the e a r ly  f ra c tio n s  on in je c tio n  in to  the v e n tra l 
lymph sac o f frogs showed to x ic i ty .  These combined d i s t i l l a t e s  were 
sa tu ra te d  w ith  sodium c h lo rid e , e x tra c te d  w ith  petroleum  e th e r , and 
the so lv en t allow ed to evaporate a t  room tem perature. The residue  was 
taken up in  25 c .c .  a lcoho l and p re c ip i ta te d  by the ad d itio n  of s a tu ­
ra te d  sodium ch lo ride  so lu tio n , a  l ig h t  brown sem i-so lid  mass r e s u l t ­
ing , This a lso  showed some to x ic i ty  to  frogs but was not in v e s tig a ted  
fu r th e r  because of a  very  meager y ie ld . Four more samples of in sec t 
flow ers were likew ise steam d i s t i l l e d ,  but the d i s t i l l a t e s  showed no 
to x ic i ty  to frogs and were found to  ex e rt no a c tio n  on iso la te d  ra b b it  
in te s t in e .  The fro g  and in te s t in e  t e s t  methods w i l l  be described  in  
d e ta i l  in  F a r t  IT o f th is  paper.
D is t i l l a t io n  o f various a lco h o lic  p e rco la te s  and m acerates was 
a lso  re so rted  to  bu t in  no case was any evidence ob ta ined  to  substan­
t i a t e  the a c t iv i ty  p re sen t in  the f i r s t  steam d i s t i l l a t e .
P a rt III*  The S i ts  of A ction o f Pyrethrum Flowers.
Pyrethrum flow ers were found to  be to x ic  to  both  warm and cold  
blooded anim als, depending upon the dosage and the  ro u te  o f adm inis­
t r a t io n  employed.
A hydro-alcoho lic  so lu tio n  o f an e x tra c t of pyrethrum flo w ers , when 
in je c te d  in to  the v e n tra l lymph sac o f a  fro g , produced in  a  very few 
m inutes, a  very marlced h y p e r i r r i t a b i l i ty ,  resem bling th a t  r e s u l t in g  from 
the ad m in is tra tio n  o f s trychn ine . The h y p e r i r r i t a b i l i ty  soon began to 
pass in to  a  s ta te  of hypo i r r i t a b i l i t y  and in  a  sh o rt time the anim al was 
com pletely para lyzed , w ith  death rap id ly  ensuing.
I f  the sp in a l cord of the f ro g  was destroyed befo re  ad m in is tra tio n  
of the  drug, the f i r s t  symptoms of h y p e r i r r i t a b i l i ty  were not m anifested . 
However, i f  the b ra in  was destroyed, leav in g  the sp in a l cord in ta c t ,  
these  symptoms were observed as in  the normal fro g . This evidence in ­
d ica ted  th a t  the drug ex erted  i t s  a c tio n  on the sp in a l cord.
An o liv e  o i l  so lu tio n  of an a c tiv e  e x tr a c t  in je c te d  subcutaneously 
in to  w hite ra ts  produced e f fe c ts  analagous to  those observed in  the f ro g .
A ty p ic a l p ro toco l fo llow s:
3:55 -  o liv e  o i l  suspension rep resen tin g  12 mgm. pyrethrum 
flow ers p e r gram r a t  adm inistered  subcutaneously.
4:00 -  symptoms of d is t r e s s .
4:05 -  increased  re f le x  e x c i ta b i l i ty
4:15 -  animal in  d e f in ite  c lo n ic  convulsive s ta te ,
4:40 -  c lo n ic  convulsions ceased and p a ra ly s is  developed.
4:45 -  re s p ira t io n  ceased.
4:47 -  ca rd iac  stoppage.
Oats a f t e r  having been fed  in se c t flow ers mixed w ith  food, over 
long p erio d s  of tim e, showed no to x ic  symptoms and appeared normal in  
a l l  re sp e c ts . However, pyrethrum so lu tio n s  adm inistered to  c a ts ,  i n t r a ­
venously o r  in tra p e r i to n o a lly , qu ickly  produced death , e sp e c ia lly  by the 
in travenous ro u te ,
A chronological o rd er of symptoms produced by in tra p e r i to n e a l in ­
je c tio n  i s  as  fo llow s:
10:43 -  o liv e  o i l  suspension of a c tiv e  pyrethrum e x tra c t  re p re ­
sen tin g  4 grams of the flow ers p e r  kgn. c a t adm in istered  
in tra p e r  i  to n ea lly ,
10:48 -  v is ib le  sigaB of discom fort.
12:00 -  abnormal movement o f h ind  leg s  in  locomotion and hyper­
a c tiv e  response to  m echanical s tim u li in  these limbs.
1:00 -  hind legs becoming hypoactive and fo re leg s  hyperac tive .
2:30 -  both  fo re  and h ind  legs non-responsive to  m echanical
s tim u li, f a s t  and labored r e s p ir a t io n , no re a d ily  dem­
o n s trab le  signs o f c e reb ra l depression , corneal r e f le x  
apparen tly  s t i l l  normal.
3:00 -  signs of ce reb ra l depression  -  corneal r e f le x  decreased.
4:12 -  re sp ira to ry  f a i lu r e .
4:15 -  c e ssa tio n  of h e a r t bea t.
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The symptoms produced in  the 
fo regoing  experim ents s tro n g ly  
in d ica ted  th a t  in sec t flow ers p ro ­
duce an ascending p a ra ly s is  o f  the 
sp in a l cord preceded by a  t r a n s i ­
to ry  s tim u la tio n .
Experim entation w ith  a view of 
detezm ining a c tio n  on the autonomic, 
nervous system was conducted but 
s ig n if ic a n t e f fe c ts  were no t appar­
en t from reasonable doses. In  F ig.
1 i t  can be seen th a t la rg e  in t r a ­
venous doses of pyrethrum flow ers 
produced no change in  blood p ressu re  
and due to th is  f a c t  i t  appears th a t  
the drug has no a c tio n  on the au to­
nomic nervous system supplying c irc u ­
la t io n  s ince any s ig n if ic a n t  e f f e c t  
a t  a l l  would have shown an a l te r a t io n  
in blood p ressu re . Three such exper­
iments were performed.
F ig . 1 -  E ffeo t of pyrethrum Flow­
ers  on C arotid  Blood P ressure.
PROOF OF SITE OF ACTION OF PYRETHRUM FUOWKRS 
The f i r s t  experiments to  prove the s i t e  of ac tio n  of in se c t flow ers 
were concerned w ith  i t s  e f fe c ts  on the  gastroonemiuB muscle and s c ia t i c  
nerve o f the frog*
APPARATUS
The apparatus co n s is ted  of a  Harvard inductorium , platinum  e lec tro d es  
to  s tim u la te  th e  m uscle, non«po l a r i  sab le  b o o t-e lec tro d es  f o r  s tim u la tio n  
of the nerve , a  m oist chamber, and a  dry c e l l  o f 1*23 v o lts  and 0*08 
amperes as a  source of current*
SBOCKDUHR
One leg  of a  sp in a l f ro g , excepting  the s c ia t ic  nerve was l ig a te d  
as h igh  up as p o ssib le  and amputated ju s t  below the l ig a tu re .  A muscle 
nerve p rep ara tio n  was made and the minimal stim ulus which e l i c i t e d  r e ­
sponse of the  muscle was detennined by s tim u la tio n  of the nerve w ith  the 
boot e le c tro d e s . Likewise by use of the platinum  e le c tro d e s , the minimal 
stim ulus causing response in  the muscle was determined by d i r e c t  s tim u la­
t io n . The re s u l ts  were recorded as the number of cen tim eters the sec­
ondary was removed from the prim ary c o ll  and a lso  the number of degrees 
the secondary was ro ta te d  from the is o -a x ia l  plane of the prim ary coil*
A sample o f  pyrethrum , in  hydro-alcoho lic  so lu tio n  con ta in ing  10$ 
a lco h o l, o f which 0*0002 grams p er gram of fro g  was predeterm ined to  p ro ­
duce p a ra ly s is  in  25 to 35 m inutes, was In je c ted  in  the same dosage in to  
the  v e n tra l lymph sac o f the frog . A fte r  45 minutes the remaining leg  
was amputated **a th e  te s t s  fo r  minimal s tim u li were conducted as f o r  the
f i r s t  leg .
Another group o f fro g s  was used as c o n tro ls . The same recordings 
were made as  fo r  the experim ental fro g s .
TA.BI2S I I .  R esu lts  o f Drug A ction on Nerve and Muscle
No. GM. Sex Before Drug A fte r  Drug
WT. Leg Nerve Muscle Leg Nerve Muscle
1 19 m. L eft 10 cm. 45° 8 cm, 40° Right 10 cm. 55° 10 cm. 0°
2 16 F. L eft 11 cm. 40° 7*8 am. 0° Right 11 cm. 40° 7 .6  cm. 0°
3 13 F. L eft 9 cm. 20° 7 cm. 0° R ight 9 cm. 30° 7 cm. 0°
4 19 M. Right 10 cm. 0° 8 cm. 25° L eft 9 cm. 20° 8 cm. 25°
5 15 M. Right 11 cm. 35° 7 .2  cm. 0° L e ft 11 cm. 35° 7 .1  cm. 0°
6 18 M. Right 10 cm. 20° 7*6 cm. 0° L eft 12 cm. 55° 7 .8  cm. 0°
C O U T R 0 L S W I T H 10$ A L O O H 0 L
7 18 F. L eft 12 cm. 60° 7 .5  cm. 0° R ight 12 cm. 30° 7 cm. 0°
8 17 M. L eft 12 cm. 40° 8 cm. 10° Right 12 cm. 40° 10 cm. 10°
9 20 M. Right 13 cm. 35° 8.2 cm. 20° L eft 12 cm. 35° 7 .9  cm. 0°
10 17 M. Right 11 cm. 55° 7 .5  cm. 0° L eft 11 cm. 55° 8 .4  cm. 0°
11 17 F. Right 10 cm. 55° 7.7 cm. 0° L eft 12 cm. 30° 8 ,4  cm. 0°
On examination of Table I I ,  i t  i s  seen th a t  small d iffe ren ces  in  in ­
te n s i ty  of stim ulus necessary  to  e l i c i t  response in  the nerve and muscle 
before and a f t e r  the drug a re  sometimes p resen t. However, comparable d i f ­
ferences a re  a lso  found in  the  co n tro ls  and th u s , i t  is  re a d ily  seen th a t 
the drug ex e rts  no a c tio n  on the muscle o r the motor nerve.
For f u r th e r  s tu d ie s , sp in a l frogs were again used , bu t h e re , the 
sp in a l cord and s c ia t i c  nerve were observed fo r  e f fe c ts  produced by the
APPARATUS
The same induetorium  and source of cu rren t were employed a s  above, 
but f in e  copper w ire e lec tro d es  were used to s tim u la te  th e  sp in a l cord  
and platinum  e lec tro d es  were used to s tim u la te  the s c ia t ic  n erv e•
PROCEDURE
The sp in a l cord , above the ju n c tio n  of the s c ia t ic  nerve (5 th  lum­
b ar v e r te b ra ) , and the s c ia t i c  nerve o f one leg  were exposed. The 
th resho ld  stim ulus was determined fo r  each and the drug adm in istered  as 
in  the previous experim ents. Then a t  various in te rv a ls ,  record ings of 
the th re sh o ld  stim uli were made. Here a ls o ,  co n tro l frogs in je c te d  w ith 
lÔ S alcohol were te s te d  and the r e s u l ts  compared to those obtained  from 
the frogs exposed to  the  drug.
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A fte r  Drug 
Time Cord Nerve
1 21 M. 8 .4  cm. 15° 10.3 cm. 60° 31 min. 6 .2  cm. 0 10.3 cm. 55°
E 15 M. 8 .4  cm. 10° 11 cm. 55° 28 « 7.1 cm, 0® 11 cm. 40°
3 21 F. 9 cm. 0° 9 cm. 30® 20 W 7,0  cm. 0° 9 cm. 35®
45 II 2 .0  cm. 0® 9 cm. 30°
4 23 F. 9 cm. 0° 9 cm. 40° 28 II 6 .3  cm. 0° 9 cm. 30°
54 It 5 .5  cm. 0° 9 cm. 50°
5 24 M. 9 cm. 20° 9 cm. 15° 40 It 6.8 cm. 0® 9 cm. 40®
6 25 u . 5.8 cm. 0° 8 .5  cm. 25° 30 11 4 .6  cm. 0® 8.5 cm. 30°
62 11 2 .2  cm. 0° 8 .5  cm. 35®
7 23 U. 4 .1  cm. 0° 9 cm. 10° 46 If 2 .3  cm. 0® 9 cm. 60°
8 22 F. 8 .5  cm. 15° 9 cm. 45° 41 II 6, 3 cm. 0° 9 cm. 55®
9 19 F. 7 .0  cm. 0° 8 .4  cm. 30° 60 It 5 .3  cm. 0° 8 .4  cm. 40®
10 E2 F. 9 .4  cm. 0° 10 cm. 35° 45 It 8 ,2  cm. 0° 10 cm. 40°
65 II 6 .4  cm. 0° 10 on. 40°
C O N T R O L S  W I T H IVfo A L 0 o :H 0 L
1 20 M. 7.  3 cm. 60° 10.8 cm. 25° 30 min. 7 .2  cm. 0° 10,9 cm, 30°
E 26 11. 7.0 cm. 0° 8 .2  cm. 0° 30 II 7 .0  cm. 0° 8 .2  cm. 0°
90 II 7 .2  cm. 0® 8 .3  cm. 45°
3 27 F. 7 .3  cm. 0° 9 cm. 20° 37 If 7 .2  cm. 0° 9 cm. 35®
87 11' 6 .8  cm. 0° 9 cm. 45°
4 25 F. 6.5 cm. 15° 10 cm. 50® 38 II 8 .5  cm. 50° 10 cm. 55®
56 II 8 .5  cm. 50® 10 cm. 40°
5 22 11. 9 cm. 30° 10 cm. 20® 40. It 9 cm. 0® 10 cm. 25®
75 If 9 cm. 15° 10 cm. 40°
6 22 F. 7.8 cm. 0° 10 cm. 20° 34 If 7 .7 cm. 0° 10 cm. 40®
69 11 7.7 cm. 0° 10 cm. 45°
Table I I I  shows ag a in  th a t th e  m otor nerve is  not a f fe c te d , but the
sp in a l cord is  d e f in i te ly  depressed because the seoondazy c o il had to  be 
brought c lo se r  to the prim ary c o il  o f the induotorium (g re a te r  stim ulus) 
in  o rd er to c a rry  the impulse down the cord and over the s c ia t i c  nerve to
e l i o i t  a  response o f the muscle. This depression  is  an ascending one 
sinoe i t  was observed in  in ta o t  anim als th a t  the hind  limbs and then the 
fo re  limbs were paralyzed . The p a ra ly s is  th e re fo re  involves the  a n te r io r  
horn o f the  cord since d ire c t  s tim u la tio n  of the cord showed the p a ra ly s is .
P roof o f the presence o r  absence o f a c tio n  on the p o s te r io r  p o rtio n  
o f the cord  was nex t undertaken.
APPARATUS
The same indue to rium as above was used w ith  two dry o e l ls  o f 3*0 
v o lts  and 51 amperes, platinum  e lec tro d es  being used f o r  purposes of 
s tim u la tio n .
PROCEDURE
Two frogs were used fo r  each experiment one being a sp in a l f ro g  and 
the o th e r a  com pletely p ith ed  f ro g , both  s c ia t ic  nerves o f the sp in a l fro g
and the  r ig h t  s c ia t ic  nerve of the com pletely p ith ed  fro g  being exposed.
/
The l e f t  s c ia t ic  nerve o f the sp in a l f ro g  and the r ig h t  s c ia t ic  nerve of 
the  com pletely p ith ed  fro g  were contacted  by means of a w ire bridge and 
the stim ulus was ap p lied  to the r ig h t  s c ia t i c  nerve of the sp in a l f ro g .
The th resh o ld  stim ulus necessary  to pass over the p o s te r io r  p o rtio n  of 
the cord o f the sp in a l f ro g , down the l e f t  s c ia t ic  nerve, in to  the r ig h t  
s c ia t i c  nerve o f  the com pletely p ith ed  f ro g , and producing a  response in  
the le g , was a sce rta in ed . Then the drug so lu tio n  was in je c te d  in to  the 
v e n tra l lymph sac o f the sp in a l fro g  and a t  various in te rv a ls  the th resh o ld  
was again  determined.
16
C ontrol fro g s were a lso  used h ere  and the  r e s u l t s  compared to  those 
obtained  from the frogs in je c te d  w ith  pyrethrum flow ers. The r e s u l ts  
were recorded the same as those in  Tables I I  and I I I .
TABUS IV. R esu lts  o f Drug A ction on P o s te r io r  Horn of Spinal Cord.
No. Gm.
Wt.
Sex Before Drug Time A fte r  Drug
1 25 M. 5 on. 0( 128 min. 2 .5 cm. 0°
2 29 F. 7 .4 cm. 0° 82 n 4.7 cm. 0°
3 25 F. 4 .9 cm. 0° 80 it 3.7 cm. 0°
4 25 F. 3.8 cm. 0° 115 n 0 .2 cm. 0° *
5 24 M. 5.7 cm. 0° 69 it 4 .1 cm. 0°
6 24 M. 4 .2 cm. 0° 90 n 0.2 cm. 0° *
7 25 U. 5 .3 ora. 0° 130 ii 2.0 cm. 0°
8 19 u . 7.0 cm. 0° 59 ii 5.6 cm. 0°
9 24 M. 6.7 cm. 0° 96 ii 2.8 cm.
10 25 F. 6 .3 cm. 0° 127 n 4 .8 cm. 0°
0 0 N T R 0 L F R 0 G S
1 20 M. 6 .5 cm. 0° 130 min. 6.2 cm. °02 25 F. 5.5 cm. 0° 114 it 5.8 cm. 0
3 24 F. 6 .3 cm. 0° 72 it 6.2 cm. 0°
4 25 M. 7.1 cm. 0° 104 it 6.8 cm. 0°
5 26 M. 8 .3 cm. 0° 140 ii 7.9 cm. 0°
A nalysis of Table IV shows th a t  depression  o f the p o s te r io r  p o rtio n  
of th e  sp in a l cord caused by drug a c tio n  i s  f a r  in  excess of the s lig h t  
changes occurring  in  th e  c o n tro l fro g s over a  period of tim e, proving 
th a t  the sensory p o rtio n  of the sp in a l cord is  depressed by the drug.
A review of a l l  r e s u l ts  thus f a r  ob tained  shows th a t  pyrethrum flow ers
* No response here . Secondary c o i l  could no t be moved c lo se r  to prim ary c o i l .
e x e r t no changes on the th re sh o ld  f o r  e i th e r  s t r ia te d  muscle o r  motor
nerves. However, the drug does depress both  the a n te r io r  and p o s te r io r
p o rtio n s  o f the cord a f t e r  a  t ra n s i to ry  p erio d  of s tim u la tio n .
This does n o t e n t i r e ly  dism iss the  p o s s ib i l i ty  of changes in  the 
phases o f an iso to n ic  co n trac tio n  of s t r i a t e d  muscle. The th re sh o ld  
stim ulus may no t be changed bu t n ev erth e less  the phases through which a
muscle passes in  an iso to n ic  c o n trac tio n  may be a l te re d .
In  determ ining the e f fe c ts  of the drug on phases o f c o n tra c tio n  o f 
s t r i a te d  m uscle, both cold and warm blooded animals were used.
PROCEDURE
For the  cold blooded animal experim ents, a  muscle nerve p re p a ra tio n  
o f a  fro g ’ s gastrocnemius muscle was made and stim u la ted  d i r e c t ly  w ith  
platinum  e le c tro d e s , record ing  the  phases by means of a kymograph* The 
muscle was i r r ig a te d  w ith  pyrethrum in  fro g  R inger1 s so lu tio n  and again  
the phases o f co n trac tio n  were recorded and compared to the o r ig in a l  
phases before  drug a c tio n .
In  the  experiments w ith  warm blooded anim als, a n e s th e tiz ed  c a ts  
were used. The proximal p o rtio n  o f the gastrocnem ius muscle was l e f t  
in ta c t  b u t the d i s t a l  tendons were detached and connected to a muscle le v ­
e r .  The phases o f co n trac tio n  produced by d ire c t  s tim u la tio n  w ith  p l a t i -  
num e lec tro d es  were recorded and the  muscle was then  i r r ig a te d  w ith  
pyrethrum so lu tio n . A fte r  considerable i r r ig a t io n  the phases were again  
recorded , the r e s u l ts  being compared to th e  o r ig in a l .
A n a ly se s  o f  th e  p h a se s  
o f  c o n t r a c t i o n  o f  th e  f r o g  
m u sc le  i n  F i g s .  2 and  3 an d  
th e  c a t  m u sc le  i n  F ig s .  4 
and  5 show no s i g n i f i c a n t  
ch an g es a f t e r  e x p o su re  o f  
th e  m uscle  to  th e  a c t i o n  o f  
p y re th ru m  f lo w e r s .
A f t e r  th e  e f f e c t s  o f  
th e  d ru g  on  s t r i a t e d  
m u sc le  w e re  a s c e r t a i n e d ,  
th e  a c t i o n  o f  p y re th ru m  f lo w e rs  
on i n t e s t i n a l  m u sc le  was n e x t  
d e te rm in e d .
PROCEDURE.
Segm ents o f r a b b i t  i n t e s ­
t i n e  from  th e  p y l o r i c  p o r t i o n  
e a c h  ab o u t one c e n t im e te r  lo n g , 
w ere  b a th e d  in  50 c . c .  o f  
T y r o d e 's  s o l u t i o n  m a in ta in e d  
a t  3 7 .5 °  0 . A f t e r  a  s u i t a b l e
c o n t r o l  r e c o r d in g  h ad  been
F ig .  3 -  F rog  g a s tro c n e m iu s  m uscle  
o b ta in e d ,  p y re th ru m  s o l u t i o n  a f t e r  d ru g  a c t i o n .
I 9/too Sec.
i l  i | •1
C Fyô  -4 -3  Q rn. Am ly*  is of I  so to pic 
Tact iotj of (xa.strocTi^7niu.s M. 
A f t e r  1 2 0  Min. I r r i^ t io T , w ith
Pytetti vu-nt S o l. F4.ya,<lic Bvea-K
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F ig . 2 -  F ro g  g a s tro c n e m iu s  m uscle  b e ­
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Fig. 4 -  Cat gastrocnemius muscle before drug 
ac tio n .
F ig . 5 -  Cat gastrocnemius muscle a f t e r  drug a c tio n .
was added, an d  th e  r e s u l t s  
n o te d .
F ig u r e  6 shows t h a t  
p y re th ru m  p ro d u c e s  a  d e ­
c r e a s e  in  a m p litu d e  o f  c o n ­
t r a c t i o n  a n d  a  d e c re a s e  in  
to n u s  o f  i s o l a t e d  r a b b i t  
i n t e s t i n e .
F o r  f u r t h e r  l o c a l i z a ­
t i o n  o f  t h i s  a c t i o n ,  th e  
r e s p o n s e  o f  th e  m u sc le  to  a  
d e f i n i t e  d o se  o f  1% b arium  
c h lo r id e  s o l u t i o n  was ob ­
s e rv e d ,  th e  b a riu m  s o l u t i o n  
w as r e p la c e d  by  new T y ro d e f s 
s o l u t i o n  a n d  p y re th ru m  ad d ed . 
A f t e r  a n  e la p s e  o f  t e n  m inu tes 
th e  o r i g i n a l  dose  o f  b a riu m  
c h lo r id e  w as a d d e d  a n d , a t  
two m in u te  i n t e r v a l s  two 
l a r g e r  d o s e s  o f  b a riu m  c h l o r ­
id e  w ere  a d m in is te r e d . F ig .  6 -  A c tio n  o f  P y re th ru m  





F ig u r e  7 shows t h a t  th e  a c t i o n  
o f  b a riu m  w h ich  i s  d i r e c t l y  on th e  
nrusole i s  i n h i b i t e d  by p y re th ru m , 
thus i n d i c a t i n g  t h a t  p y re th ru m  
a c t s  d i r e c t l y  on i n t e s t i n a l  m us­
c u l a t u r e .
F ig ,  7 -  P y re th ru m  I n h i b i t i o n  o f














P a r t  17. The B io log ical Assay of Pyrethrum Flowers.
The assay  o f pyrethrum flow ers has heen the  o b jec t of much research  
in  re c e n t y e a rs , numerous chemical and b io lo g ic a l methods having been 
proposed and used by various t e s t  la b o ra to r ie s . The b e s t chemical meth­
ods and the f ly  method which appears to be the p ee r o f the b io lo g ic a l 
assay  procedures, req u ire  e i th e r  e lab o ra te  apparatus o r  consume very 
much tim e. In  a d d itio n , many in v e s tig a to rs  a re  unable to agree on the 
su p e rio r s u i t a b i l i t y  of any one method.
In  view of these f a c t s ,  C hevalier (E l) ,  and C hevalier and B ip e rt (EE) 
have suggested th e  use o f frogs a s  a  t e s t  o b je c t, and F e rro t and Graudin (23) 
and B ig a l (24) have used iso la te d  ra b b it  in te s t in e  as a  means of evaluat** 
ing pyrethrum flow ers.
In  th is  work, bo th  of these suggestions were f u r th e r  in v e s tig a ted  
a  method has been developed from each.
THE OVERNIGHT 5B0G METHOD OF ASSAY 
Various symptoms produced by pyrethrum flow ers on the f ro g  were con­
s id e red  as  possib le  end p o in ts  in  determ ining the potency of unknown 
samples of drug i t  was f in a l ly  concluded th a t overnight m o rta lity  was 
the b e s t end p o in t. This n e c e s s ita te d  the p rep ara tio n  o f a  m o rta lity  
(yorve in  o rd er to compare the re la t iv e  s tre n g th s  of an unknown pyrethrum 
the  one th a t  would be used as a  standard.
PREPARATION OP MORTALITY CURVE
APPARATUS
The apparatus co n s is ted  o f a  storage tank f o r  the fro g s  w ith  con­
s ta n t  running w ater a t  a  tem perature he low 15° C in  o rd er to  reduoe the 
m etabolic r a te  o f the f ro g s , so th a t  feed ing  would no t be necessary . A 
la rg e  tank  th e  tem perature of which could be m aintained a t  S0° 0 -0 ,5 °  0, 
equipped w ith  in d iv id u a l compartments, was used fo r  keeping the fro g s 
overn ight a f t e r  ad m in is tra tio n  o f the  drug. The in d iv id u a l compartments 
had no bottom and were p laced  on w ire sc reen s , immersed in  the w ater to 
a  depth o f about one cen tim eter,
ANIMALS
The fro g s  used in  the p re p a ra tio n  of the m o rta li ty  curve weighed 
from 15 to  35 grams and were s to red  in  the tank w ith  running w ater be­
low 15° C, f o r  one week befo re  u se ,
PROCEDURE
Seven s e r ie s  o f f ro g s , each s e r ie s  o f one sex weighing w ith in  a 
range of 5 grams, were d iv ided  in to  e ig h t groups, each group of equal num­
b e r ranging from 10 to  25 fro g s  depending on the number a v a ila b le . On d if ­
f e re n t  days, 24 hours befo re  u se , each s e r ie s  of frogs was removed from 
th e  s to rag e  tank and p laced  in  the in d iv id u a l compartments a t  20° C-0.5^0. 
Before ad m in is tra tio n  o f the drug, each f ro g  was d ried  w ith  a  tow el, the 
u r in e  expressed, and the  weight recorded w itiiin one h a lf  gram. The drug
24
was used as a  10$ m acerate in  a lco h o l, d i lu te d  w ith  d i s t i l l e d  w ater so 
th a t  th e  so lu tio n  contained le s s  than 25$ a lcohol and so th a t  no fro g  
received  more than 0,02 cc p e r  gram. The same 10$ a lco h o lic  m acerate 
was used in  a l l  the seven s e r ie s  of frogs bu t the d ilu tio n s  were p re ­
pared as needed f o r  each group of fro g s . E ight doses, one fo r  each 
group of each s e r ie s ,  were se le c ted  so th a t  the low est dose produced 
no m o rta lity  and th e  h ig h est dose produced 100$ m o rta lity . The fro g s  
o f each group were in je c te d  into the v e n tra l lymph sac w ith  the assigned  
doses and each fro g  was p laced  in  i t s  sep ara te  compartment. The fo llow ­
ing day, th e  frogs were examined and the percentage m o rta li ty  was r e ­
corded fo r  each dose. A curve was p lo tte d  fo r  each s e r ie s  o f f ro g s , Fig.8,
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8 -  Frog m o rta lity  curves.
B ig. 9 -  P rog  m o r t a l i ty  cu rv es  superim posed, on a  50$ p o in t .
P ig .  10 -  C om posite  o f  a l l  r e s u l t s .
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and a l l  o f  the  curves were then superimposed on a  50$ p o in t, F ig , 9, 
F in a l ly ,  the various percentage m o r ta l i t ie s  were averaged and a  compos­
i t e  curve o f  a l l  th e  in d iv id u al r e s u l ts  was p repared , F ig , 10,
From the composite curve, dose numbers fo r  a l l  p o ssib le  percentage 
m o r ta l i t ie s ,  based on the use o f 25 fro g s , were c a lcu la te d  and recorded 
fo r  use in  o b ta in in g  the potency o f an unknown pyre thrum in  terms o f a 
standard  pyre thrum,
TABIiTS V. Dose Numbers Corresponding to  Percentage M o rta lity .
P ercen t




M o rta lity
Dose
Number
0 2,17 52 2,65
4 2,20 56 2.70
8 2,23 60 2.75
12 2,27 64 2,80
16 2,30 68 2,85
20 2 ,33 72 2,91
24 2.37 76 2.97
28 2,41 80 3.03
32 2.44 84 3.10
36 2,48 88 3.17
40 2,52 92 3.24
44 2.56 96 3.32
48 2,60 100 3.40
ASSAY PROCEDURE
APPARATUS AND ANIMALS
The apparatus and animal requirem ents a re  the  same a s  f o r  the p repar­
a t io n  o f the curves.
SOLUTIONS
The drug i f  n o t a lread y  ground i s  reduced to a No. 40, or f in e r ,  
powder. Five grains o f both  the standard  and unknown powders a re  accu­
r a te ly  weighed and p laced  in  sep ara te  25 c .c .  volum etric f la s k s .  Suf­
f ic ie n t  a lco h o l i s  added to each to  make 25 c .c .  and the so lu tio n s  are  
p laced  in  the dark a t  1-2° C fo r  24 h ours, w ith  occasional a g i ta t io n  
a f t e r  which they a re  ready fo r  use . The so lu tio n  i s  brought to  room tem­
p e ra tu re  befo re  use and the supernatan t f lu id  i s  decanted w ithout shaking.
ASSAY PROCEDURE
Frogs weighing between 15 and 35 grams and of one sex a re  used in  
the assay . For any one de term ination , the fro g s  must a l l  weigh w ith in  a 
range of f iv e  grams. The d ilu te d  so lu tio n s  f o r  in je c tio n  must n o t have 
an a lco h o l con ten t of more than 28$ and i f  necessary , any excess alcohol 
i s  removed w ith  a  c u rren t of a i r .  Not le s s  than 0.01 c .c .  nor more than 
0.02 c .c .  p e r  gram fro g  may be in je c te d , no fro g  rece iv in g  a dose of le s s  
than 0 .25  c .c .  The dose of both standard  and unknown producing a  m orta l­
i t y  o f approxim ately 50$ is  determined by in je c tin g  vary ing  doses in to  
groups of th re e  fro g s  to each dose. The frogs a re  kept below 15° C u n t i l
4-
24 hours "before the a ssay  and then removed to  a  20° 0 -0 ,5 °  C tem perature. 
They a re  d r ie d  w ith  a  tow el, u r in e  expressed , and weighed to w ith in  0 ,5  
grams ju s t  p r io r  to th e i r  use. A fte r  o r ie n ta tio n  of the 50$ m o rta lity  
dose fo r  ho th  s tandard  and unknown, 50 fro g s  o f the above sp e c if ic a tio n s  
a re  s e le c te d , and 25 in je c te d  w ith  each the standard and unknown. The 
fo llow ing day, the m o rta lity  percentages a re  determ ined and by means o f 
the curve dose numbers the  potency of the  unknown is  determ ined in  terms 
o f the  s tandard . The percentage m o r ta l i t ie s  may be from 20$ to 80$ but 
never below or above these f ig u re s . The fro g s  which recover may be used 
again  in  p re lim in ary  o r ie n ta tio n  o f dosage, but never in  f in a l  determ in­
a t io n s ,
DISCUSSION OP A TYPICAL PROG ASSAY 
Prom experience, i t  has bean found th a t  pyrethrum flow ers do not 
have as wide a  range of potency in  terms of a good commercial sample, 
which may be chosen fo r  a  s tan d ard , as do many o th e r drugs. The potency 
may vary  from 0$ to  150$ bu t never has the worker obtained  a sample th a t 
assayed above th is  f ig u re , Por th is  reason , in  o r ie n tin g  the overnight 
M .L.D., n o t so wide a  range of doses is  necessary  and one p re lim inary  
datezm ination o f th ree  fro g s  to  each dose o fte n  s u ff ic e s , e sp e c ia lly , i f  
the as  say is  t  has c a rr ie d  out recen t determ inations and knows the approxi­
mate M.L.D. of the standard . I f  such is  no t the case, two prelim inary
te s t s  may be necessary . The o b jec t in  view is  to f in d  the dose which 
w i l l  r e s u l t  in  a  m o rta lity  as near 50$ as p o ss ib le .
For the  sake o f exp lan atio n  o f the p re lim in ary  assay , i t  i s  assumed 
th a t  from previous r e s u l t s ,  i t  i s  known th a t  0*0004 grams p e r  gram f ro g , 
of the s tan d ard , re su lte d  in  approxim ately 60$ m o rta lity . This dose can 
he used f o r  the  standard  in  the f in a l  assay , s ince th is  f ig u re  does no t 
vary g re a tly  in  monthly p erio d s. For the unknown, doses a re  se le c te d  
which a re  hased on 0.0004 goo. p e r  gram fro g  as the 50$ M.L.D. of a  100$ 
drug o r  the equ iva len t of the standard . The doses of the unknown a re  c a l 
cu la ted  on the b a s is  o f p o s s ib i l i t i e s  of 25, 50, 75, 100, 125, and 150 
p e r cent o f the standard . The so lu tio n  is  p ro p erly  d ilu te d  and in je c te d  
in to  the v e n tra l lymph sacs of th re e  fro g s  f o r  each dose. The fo llow ing  
day the r e s u l ts  a re  found to be, fo r  example, as fo llo w s:
Suspected potency Orams p e r gram fro g  R esu lts  o f  3 frogs
150$ 0.000266 — — —
125$ 0.000320 — + —
100$ 0.000400
75$ 0.000533 4 "
50$ 0.000800
■4* + +
25$ 0.001600 •|i. 4“ ■+*
These r e s u l ts  show th a t  the 50$ M.L.D. of the unknown l i e s  between 
0.000320 and 0.00040 grams drug p e r gram fro g .
For the f in a l  assay , the average, 0.00036 grams per gram fro g , is
used as the  dose and 25 frogs a re  in jec ted . Likewise, 25 frogs are  in -
ja c te d  with. 0*00040 grams standard  p e r  gram frog*
The fo llow ing  day i t  i s  found, fo r  example, th a t  the s tandard  p ro ­
duced 52$ m o rta lity  and the unknown produced 36$ m o rta lity .
C onsulting Table 7 , i t  is  seen th a t
0*0004 grams (S) •* 52$ m o rta li ty  = 2*65 dose number
4
0*00036 gram (X) = 36$ m o rta li ty  = 2*48 dose number
Thus 0*00036 grams (X) m u ltip lie d  by 2*65 « 0*0004 gram (S ).
2.48
0«000384 gram (X) = 0*0004 gram (S)
1*0 gram (X) =- 1.042 gram (S)
(X) = 104$ o f (S)
THE BARIUM INHIBITION OR ISOLATED RABBIT INTESTINE METHOD OP ASSAY
I t  has been p rev io u sly  shown th a t  pyre thrum flow ers decrease am pli­
tude and tonus o f ra b b it  in te s t in e ,  F ig . 6, and th a t th is  ac tio n  is  ex­
e r te d  d ire c t ly  on the muscle, F ig. 7 , since the e f f e c t  o f barium on the
in te s t in e  i s  in h ib ite d  by pyrethrum. On fu r th e r  in v e s tig a tio n , i t  was 
found th a t th is  in h ib i t io n  occurs q u a n ti ta t iv e ly  and fo r  th is  reason , the  
re a c tio n  has been u t i l i z e d  as the b as is  o f a method of B io log ica l assay .
APPARATUS
The apparatus f o r  th is  assay co n sis ted  o f an I so la te d  tis s u e  bath  
equipped w ith  two 50 c .c .  t is s u e  chambers and a constan t tem perature
co n tro l. The t is s u e  chambers were so equipped th a t  they could he emptied 
and r e f i l l e d  w ith  the t is s u e  ha th ing  f lu id  w ithout undue exposure o f  the 
t is s u e  to  a i r .  The chambers were a lso  equipped w ith  an oxygen supply 
which could he reg u la ted  a s  necessary  fo r  various t is s u e s .
TISSUE
The t is s u e  was ob tained  from the p y lo ric  p o rtio n  o f the r a b b i t 's  
in te s t in e ,  the ra b b it  being p re fe rab ly  a  mature one.
SOLUTIONS
The pyre thrum so lu tio n s  f o r  th i s  assay  were prepared as fo r  the 
fro g  method. The barium so lu tio n  co n sis ted  of a  su ita b le  s tre n g th  (usu­
a l l y  1$) so lu tio n  of barium ch lo rid e  in  d i s t i l l e d  w ater and Tyrode's 
so lu tio n  was used a s  the bath ing  f lu id  fo r  the  t is s u e s .
ASSAY PBDCEDURE
The ra b b it  i s  K illed  by a  blow on the head and approxim ately 50 
cen tim eters of the p y lo ric  p o rtio n  of the in te s t in e  a re  removed. The 
e x tirp a te d  t is s u e  is  p laced  in  a  beaker contain ing  Tyrode's so lu tio n  and 
may be used immediately. The remainder of the  t i s s u e ,  a f t e r  the  f i r s t  
s t r ip s  a re  taken f o r  use , is  kept a t  1-2° C. Two 1 . 5 - 2  cen tim eter po r­
tio n s  o f the in te s t in e ,  both of equal len g th , a re  out and suspended in  each 
o f  the t is s u e  chambers and the upper ends a re  a ttached  to su ita b le  magni­
fy in g  lev e rs  in  o rder to record  the r e s u lts .  The oxygen is  ad ju sted  as
necessary  f o r  the two s t r i p s  of t i s s u e ,  oare ■being taken th a t  both  .re ­
ce ive  ex ac tly  the same supply. The tem perature i s  m aintained between 
37*5° G and 38° G. Tension is  ap p lied , the same to  both t i s s u e s ,  as nec­
e ssa ry , and the t is s u e  i s  allow ed to re la x . Then s im ila r  doses o f b a r i ­
um a re  added to  each chamber, u su a lly  0*2 to 0*4 c .c . being s u f f ic ie n t ,  
and a  s ig n i f ic a n t  response of 2 to  4 minutes d u ra tio n  i s  recorded. A 1% 
so lu tio n  of barium ch lo ride  u su a lly  su ff ic e s  bu t o o cassionally  i t  i s  nec­
essary  to  use a  2 o r TSji so lu tio n . A fte r  record ing  the f i r s t  response, 
the ba th ing  f lu id  i s  removed, new f lu id  i s  in troduced , and the t is s u e s  
a re  allow ed to  re lax . F in a lly  equal doses, sm aller than the f i r s t ,  a re  
added to each chamber and the responses a re  recorded. These l a t t e r  doses 
enable the a s s a y is t  to d e tem in e  whether o r n o t the t is s u e s  a re  re a c tin g  
c o n s is te n tly , and a lso  insures ag a in s t a  maximal response, which i s  shown 
by the second response being le s s  than the f i r s t .  I f  the reac tio n s  a re  
co n s is te n t and a  submaximal response has been ob ta ined , these responses 
a re  accepted  as co n tro ls .
The t is s u e s  a re  again f ree d  of the Tyrodef s so lu tio n  con ta in ing  the 
barium, and new Tyrode*s so lu tio n  is  introduced. Next, the unknown 
pyrethrum so lu tio n  i s  added to one chamber immediately a f t e r  washing; 
and one minute l a t e r ,  the s tandard  pyrethrum so lu tio n  i s  added to the 
o th e r chamber. U sually , 0.25 c .c . to 0 .5  c .c .  of a  1 to  3 d ilu tio n  of 
the s to ck  so lu tio n  of pyrethrum (Tyrode's so lu tio n  being the d ilu e n t)  is  
s a t i s f a c to ry  to  in h ib i t  the q u a n titie s  of barium suggested above. Ten
minutes l a t e r ,  the o r ig in a l  submaximal dose of barium i s  added to  each 
chamber con ta in ing  re sp e c tiv e ly  the above-mentioned pyrethrum so lu tio n . 
A f te r  the t is s u e s  re tu rn  to the  base l in e ,  two subsequent doses of b a r i ­
um a re  added to each chamber. The second and the th i rd  doses a re  u su a lly  
twice and th ree  times the s tre n g th  of the f i r s t  dose, re sp e c tiv e ly . From 
the degree of in h ib it io n  produced by both the s tandard  and unknown p y re th ­
rum s o lu tio n s , the potency o f the unknown is  determ ined in  terms of the 
standard . New s t r ip s  a re  req u ired  fo r  each d e te im ination , s ince the  t i s ­
sues do no t recover w ith in  a  reasonable p e rio d  of time.
A TYPICAL ASSAY BY THE BARIUM INHIBITION METHOD 
A lthougi th e  in te s t in e  removed from the ra b b it  f o r  use in  th is  p ro ­
cedure i s  always s a tis fa c to ry  f o r  one day*s u se , i t  was p o s s ib le , w ith  
p a tie n c e , to  su cc e ss fu lly  use s tr ip s  from the same in te s t in e  f o r  two o r 
even th ree  days. However, on the second o r th i r d  day, the t is s u e  responds 
very  slowly and f o r  the saving o f  tim e i t  is  recommended th a t  new tis s u e  
be used each day.
New s t r ip s  a re  used fo r  each determ ination  although evidence is  a t  
hand which show  th a t  th e  drug e f fe c ts  can be washed out and the t is s u e s  
used again . The washing and subsequent recovery a re  very prolonged, and 
s in ce  an abundance o f t is s u e  is  av a ilab le  f o r  one day9 s work, the lo ss  of 
time in  w a itin g  f o r  recovery i s  n o t ju s t i f i a b le .
In  the in te rp re ta t io n  of the r e s u l ts  which a re  obtained , i t  is  re a d ily  
seen in  F ig . 11, the f i r s t  de te im ination  of a ty p ic a l  assay , in  which lik e
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d o s e s  o f  A a n d  I  w e re  u s e d ,  t h a t  I  p ro d u c e d  g r e a t e r  i n h i b i t i o n  o f  b a riu m  
re s p o n s e  th a n  A , th u s  b e in g  m ore th a n  107$ o f  th e  p o te n c y  o f  A.
F ig , 11. A ssay o f  I  in  te im s o f  A.
I n  F ig .  12 , th e  d o se  o f  A was in c r e a s e d  to  0 ,4  c . c .  w h i le  th e  o r i g i n ­
a l  dose  o f  I  was r e t a i n e d ,  an d  a s  a  r e s u l t  i t  i s  a p p a re n t  t h a t  t h i s  d o se  o f  
A i s  m ore p o t e n t  th an  th e  do se  o f  I ;  t h e r e f o r e  I  i s  l e s s  th a n  142$ o f  A.
A -0 7 1 2 3  g ~ /« .c. 
|> > O j)S C 6 G n*-/c*c.
£)*■ I /• 6>Clt S®l*
7-re-35
F ig .  12. A ssay  o f  I  in  te rm s o f  A.
F ig .  13 shows 0 ,2 5  c . c .  o f  I  to  he  more p o te n t  th a n  0 .3  c . c .  o f  A. 
T h e re fo re  I  i s  g r e a t e r  th a n  128$ o f A.
From th e s e  r e s u l t s  i t  i s  s e e n  t h a t  th e  p o te n c y  o f  I i s  b e tw een  128$ 
and  142$ o f  A. F o r  com m erc ia l p u r p o s e s ,  any  f u r t h e r  a t t e m p ts  to  o r i e n t  
th e  p o te n c y  a r e  n o t  n e c e s s a r y  and  an  a v e ra g e  o f  th e  two f i g u r e s ,  w h ich  i s  
135$ may he a s s ig n e d  to  I .  F u r th e r  in c r e a s e  in  t h e  num ber o f  d e te r m in a ­
t i o n s  p e r m i t  o f  somewhat g r e a t e r  p r e c i s io n .
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F ig , 13. A asay o f  I  in  term s o f  A.
The d i l u t i o n s  o f  th e  s to c k  m a c e ra te  o f  th e  d ru g  m ust be p r e p a r e d  e a ch  
day  a s  th e y  lo s e  p o te n c y  r a p id ly  a f t e r  d i l u t i o n .  F ig . 14 in  w h ich  th e  d i ­
l u t i o n  o f  A was 24 h o u rs  o l d ,  shows I  to  be g r e a t e r  th a n  160$ o f  A, w h ile  
F ig .  1 5 , i n  w h ich  a  new d i l u t i o n  o f  A was u s e d , shows I  to  be much l e s s  th a n  
160$ a s  com pared  to  A. F ig s .  11 , 12 and  13 b e a r  o u t th e  f a c t  t h a t  I  i s  
much l a s s  th a n  160$ o f A.
A= .07IZ3 •«-
I ' "06666 Grin- y c t. 
B*= \'/, BiClj Sol.
7 - 1 6 3 5
1.0 0*
56* i.ODi
F ig .  14. A ssay  o f  I  in  te im s o f  A u s in g  24 h o u r o ld  
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Fig . 15. Assay o f  I in  terms o f  A using neW d ilu tlo n  Qf ^
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The p e r c e n ta g e  i n h i b i t i o n  p ro d u c e d  by th e  p y re th ru m  in  t h i s  a s s a y  
i s  o f  g r e a t  im p o r ta n c e . I f  to o  much i n h i b i t i o n  o f  b a riu m  i s  o b t a in e d ,  
th e  r e l a t i v e  p o t e n c i e s  o f  th e  two p r e p a r a t i o n s  c a n n o t be e a s i l y  d ed u ced . 
P ig .  16 shows c l e a r l y  t h a t ,  w i th  th e  g r e a t  d e g re e  o f  i n h i b i t i o n  o b ta in e d ,  
i t  i s  n o t  p o s s i b l e  to  a s s i g n  a  p o te n c y  f o r  F in  te rm s  o f  A. The p y r e t h ­
rum d o sag e  m u st be  so s e l e c t e d  a s  to  p r o v id e  a  d e f i n i t e  b a riu m  re s p o n s e  
a t  th e  e n d  o f  th e  te n -m in u te  p e r io d .
1 1 1 1 1 1
1 1
A  F
Tim« in min utts
jljj A= *07123 G c - m . / c - c .
|  F -  06666 G™ ./,.,.
m  I *h BaCU Sol
Fig. 16. Assay of F in  terms of A.
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The a d v i s a b i l i t y  
o f  u s i n g  m ore th a n  one 
d o se  o f  ’b a riu m , f o l lo w in g  
th e  t e n  m in u te  e la p s e  o f  
t im e  f o r  t h e  p r o d u c t io n  
o f  p y re th ru m  p a r a l y s i s ,  
i s  d e m o n s tra te d  i n  P ig .
17. The f i r s t  a d d i t i o n  
o f  b a riu m  shows 0 .3 5  c c .
D to  be a p p ro x im a te ly  a s  
s t r o n g  o r  p o s s ib l y  s l i g h t ­
l y  w e a k e r  th a n  0 .2 5  c c .
A, b u t  th e  two s u b s e q u e n t 
d o s e s  rem ove any  t r a c e  o f  
d o u b t ,  show ing  D to  be 
d e f i n i t e l y  l e s s  p o te n t  
th a n  A.
T h is  m ethod o f  a s s a y  
i s  a c c u r a t e ,  w i th o u t  d i f f -  
c u l t y ,  w i t h i n  p lu s  o r  m inus 
10$ . On v a r io u s  o c c a s s io n s
th e  w r i t e  o b ta in e d  an  a c ­
c u ra c y  w i t h in  p lu s  o r  m inus
Pig. 17. Assay of D in  terms of A.
5 $ , w han a s s a y in g  d i f f e r e n t  d i l u t i o n s  o f  one p r e p a r a t i o n ,  p r e p a r e d  "by 
o t h e r  m em bers o f  th e  l a b o r a t o r y ,  th e  w r i t e r  b e in g  t o t a l l y  w i th o u t  know­
le d g e  o f  t h e i r  r e l a t i v e  p o te n c ie s *
APPLICATION OP THE NEW BIOASSAY METHODS 
Ten co m m erc ia l sa m p le s  o f  p y re th ru m  f lo w e r s  w ere  o b ta in e d  and  id e n ­
t i f i e d  a s  A to  J  i n c l u s i v e .  Sam ple A , w h ic h  w as c o n s id e r e d  to  be a  good 
c o n a n e rc ia l sa m p le , w as u s e d  a s  th e  s ta n d a r d .  I t  was p r e s e r v e d  in  am p u ls , 
i n  th e  d a r k ,  a t  1 -2 °  C, E ach  am pul c o n ta in e d  a p p ro x im a te ly  f i v e  g ram s, 
w h ic h  i s  th e  q u a n t i t y  i n d i c a t e d  f o r  u se  in  th e  a s s a y  p r o c e d u r e s .
The r e m a in in g  n in e  sam p le s  w ere a s s a y e d  in  te rm s o f  A by th e  two 
new m eth o d s  a n d  i n  a d d i t i o n ,  by  th e  S e i l  c h e m ic a l m ethod  (25 ) and  th e  
P e e t-G ra d y  f l y  m ethod  ( 2 6 ) .
TABLE VI. R e s u l t s  o f  A ssays
Sam- T o ta l P y r e - P y r e - P ly P o te n c y  i n  te rm s  o f P o te n c y  "by
p ie P y re - t h r i n  I t h r i n  I I K i l l T o ta l  P y r e -  P y r e - P ro g  I n t e s -
t h r i n C o n te n t C o n te n t i n  24 P y r e -  t h r i n  I  t h r i n  I I M e th - t i n e
C o n te n t h o u rs t h r i n s  C o n te n t C o n te n t o d  M ethod
A 0 ,8 1 $ 0 . 361$ 0 .4 4 9 $ 68$ - r  — — ________ ------------
B 0 .3 2 $ 0 .133$ 0 ,1 8 7 $ 4 8$ . 40$ 37$ 42$ 41$ 25$
C 0 .1 2 1 $ 0 .062$ 0 .0 5 9 $ 16$ 15$ 17$ 14$ 25$ 25$
D 0 .8 0 $ 0.344$ 0 .4 5 6 $ 83$ 99$ 95$ 102$ 86$ 99$
E 0 .8 7 $ 0. 371$ 0 .499$ 89$ 107$ 103$ 111$ 62$ 133$
P 0 .8  3$ 0. 365$ 0 .4 6 5 $ 88$ 102$ 101$ 104$ 98$ 91$
G 0 .8 7 $ 0 . 375$ 0 ,4 9 5 $ 80$ 107$ 104$ 110$ 89$ 109$
H 0 .7 6 $ 0 . 350$ 0 .4 1 0 $ 6 9$ 94$ 97$ 91$ 86$ 107$
I 0 .7 7 $ 0. 364$ 0 .4 0 6 $ 11$ 95$ 101$ 94$ 64$ 135$
J 0 . 835$ 0. 365$ 0 .4 7 0 $ 84$ 103$ 101$ 105$ 60$ 125$
D isc u s s io n  o f  R e s u l t s  o f  A ssays.
The r e s u l t s  i n  T a b le  VI show t h a t  th e  r e s u l t s  o b ta in e d  by th e  f r o g  
a n d  i s o l a t e d  r a b b i t  i n t e s t i n e  m ethods o f  a s s a y ,  a r e  n o t  a lw ays i n  good  
a g re e m e n t w i t h  th o s e  r e s u l t i n g  from  t h e  c h e m ic a l a s s a y .
The f r o g  a s s a y s ,  w h i le  show ing  good a g re e m e n t w i t h  th e  c h e m ic a l 
a s s a y ,  in v o lv in g  s i x  o f  th e  s a m p le s , show low r e s u l t s  in  th e  re m a in in g  
t h r e e  sa m p le s .
The i s o l a t e d  i n t e s t i n e  d e te r m in a t io n s  show good a g re e m e n t w i th  th e  
c h e m ic a l  a s s a y s  i n  s i x  o f  th e  c o m p a riso n s  an d  show no g r e a t  d i s a g r e e ­
m ent i n  th e  re m a in in g  t h r e e  t e s t s .
I t  i s  s i g n i f i c a n t  to  n o te  t h a t  t h e  d is a g re e m e n ts  o f b o th  o f  th e  
b i o l o g i c a l  m ethods w i th  t h e  c h e m ic a l m ethod  o c c u r  in  th e  same s a m p le s , 
th e  f r o g  a s s a y  sh o w in g  a  lo w e r  p o te n c y  and  th e  i s o l a t e d  i n t e s t i n e  a s s a y  
show ing  a  h ig h e r  p o te n c y  th a n  th e  c h e m ic a l  a s s a y .
I n  some i n s t a n c e s ,  th e  p e rc e n ta g e  f l y  k i l l  shows some ag reem en t 
w i th  t h e  a s s a y  r e s u l t s  of th e  o t h e r  m e th o d s , b u t th e  a b se n c e  o f  a  
s t a n d a r d  o f  c o m p a riso n  d e p r iv e s  th e  f l y  r e s u l t s  o f  any  g r e a t  s i g n i f i c a n c e ,  
sh o w in g  o n ly  th e  r e l a t i v e  p o s i t i v e  o r  n e g a t iv e  f l y  k i l l i n g  pow ers o f a  
sam ple  o f  p y re th ru m  f lo w e r s .
Summary and  C o n c lu s io n s
1 P y re th ru m , by th e  m ethods so f a r  em ployed ,w as fo u n d  to  c o n ta in  
no v o l a t i l e  a c t i v e  c o n s t i tu e n t*
2 . P y re th ru m  f lo w e r s  a r e  to x ic  to  b o th  warm and. c o ld  b lo o d e d  a n im a ls  
d e p e n d in g  upon  th e  d o sa g e  an d  r o u te  o f  a d m i n i s t r a t i o n .
3* C o ld  b lo o d e d  a n im a ls  ( f r o g ,  ea rth w o rm , and  i n s e c t s )  a r e  much more 
s u s c e p t i b l e  to  th e  a c t i o n  o f  p y re th ru m  th a n  warm b lo o d e d  a n im a ls  ( r a t ,  
c a t ,  a n d  g u in e a  p i g ) .
4 . S l s e le ta l  m u sc le  a n d  th e  m o to r  n e rv e s  s u p p ly in g  t h i s  ty p e  o f 
m u sc le  a r e  n o t  a f f e c t e d  by  p y re th ru m  f lo w e r s .
5 .  P y re th ru m  f lo w e r s  p ro d u ce  a  t r a n s i t o r y  s t i m u la t i o n  o f  b o th  th e  
a n t e r i o r  a n d  p o s t e r i o r  h o rn s  o f  th e  s p i n a l  c o r d ,  f o l lo w e d  by an  in te n s e  
d e p r e s s io n .
6 . The p r i n c i p l e  s i t e  o f  a c t i o n  o f  p y re th ru m  i s  th e  s p in a l  c o rd .
The c h a r a c t e r  o f  th e  a c t i o n  may be  d e s c r ib e d  a s  a  t r a n s i t o r y  s t i m u la t i o n  
f o l lo w e d  by  d e p r e s s io n  an d  p a r a l y s i s  o f  a  d i s t i n c t l y  a s c e n d in g  ty p e ,  
u l t i m a t e l y  r e a c h in g  th e  m e d u l la ry  c e n t e r s .
7 . The a u to n o m ic  n e rv o u s  sy s tem  a p p e a r s  n o t  to  be d i r e c t l y  a f f e c t e d  
by  p y re th ru m  f lo w e r s .  Any a l t e r a t i o n  in  f u n c t i o n  o f a u to n o m ic a l ly  c o n ­
t r o l l e d  o rg a n s  a r e  s l i g h t ,  a n d  a r e  in d u c e d  r e f l e x l y .
8 . R a b b i t  i n t e s t i n e  i s  d e p re s s e d  by p y re th ru m  f lo w e r s ,  t h e  d ru g  e x ­
e r t i n g  i t s  a c t i o n  d i r e c t l y  on th e  m u s c u la tu r e .
9 . Two new methods o f  a s s a y ,  the O v e rn ig h t F rog  and I s o l a t e d  R a b b i t  
I n te s t in e  methods h av e  b een  developed and u se d  f o r  a ssa y  purposes.
10 N ine  sam p les  o f  p y re th ru m  f lo w e r s  have b e e n  a s s a y e d  in  t e r n s  o f 
a  r e f e r e n c e  s t a n d a r d ,  b y  th e  S e l l  c h e m ic a l  m eth o d , a n d  P e e t-G ra d y  f l y
m e th o d , a n d  th e  two new " b io lo g ic a l  a s s a y  m eth o d s .
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